Milsora Pharmaceuticals (Developer of lung cancer therapies from medical-grade olive oil)

Milsora Pharmaceuticals is the world’s first creator and producer of the Medical Olive Oil concept, based on its 2022 patent filing. With a dedicated focus on pharmaceutical innovation and evidence-based health applications, we aim to address some of the world’s deadliest diseases — starting with lung cancer. At Milsora Pharmaceuticals, we are pioneering a new frontier where nature meets biotechnology. Our groundbreaking approach leverages high-phenolic olive oil — particularly compounds such as oleocanthal and hydroxytyrosol — as a scientifically promising therapeutic pathway for lung cancer treatment. Rooted in the Mediterranean, powered by science, and guided by purpose, we blend centuries-old health traditions with cutting-edge drug development. Our global vision extends across borders. We are actively fostering research and production partnerships in the United States, Türkiye, Greece, and Israel, building bridges between science hubs to accelerate biopharmaceutical progress and patient impact. At Milsora, we don't just formulate therapies. We redefine the future of medicine — olive by olive, cell by cell.